Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TUBB4A | P04350 | 4/20 | 0.80 |
| ▸ | TUBB | P07437 | 4/20 | 0.80 |
| ▸ | TUBA3C | P0DPH7 | 4/20 | 0.80 |
| ▸ | TUBA1B | P68363 | 4/20 | 0.80 |
| ▸ | TUBA4A | P68366 | 4/20 | 0.80 |
| ▸ | TUBB4B | P68371 | 4/20 | 0.80 |
| ▸ | TUBB3 | Q13509 | 4/20 | 0.80 |
| ▸ | TUBB2A | Q13885 | 4/20 | 0.80 |
| ▸ | TUBB8 | Q3ZCM7 | 4/20 | 0.80 |
| ▸ | TUBA3E | Q6PEY2 | 4/20 | 0.80 |
| ▸ | TUBA1A | Q71U36 | 4/20 | 0.80 |
| ▸ | TUBA1C | Q9BQE3 | 4/20 | 0.80 |
| ▸ | TUBB6 | Q9BUF5 | 4/20 | 0.80 |
| ▸ | TUBB2B | Q9BVA1 | 4/20 | 0.80 |
| ▸ | TUBB1 | Q9H4B7 | 4/20 | 0.80 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.76 |
| ▸ | TSHR | P16473 | 1/20 | 0.76 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.76 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.76 |
| ▸ | P4HB | P07237 | 1/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29417872 | 0.95 | TUBB4A (0.81) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL12530882 | 0.95 | TUBB4A (0.81) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL12530451 | 0.95 | TUBB4A (0.81) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL14850594 | 0.93 | TUBB4A (0.84) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL15046116 | 0.93 | TUBB4A (0.84) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL18746261 | 0.93 | TUBB4A (0.86) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL24541099 | 0.92 | TUBB4A (0.82) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL20254102 | 0.92 | TUBB4A (0.66) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL20253913 | 0.92 | TUBB4A (0.66) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL20254103 | 0.92 | TUBB4A (0.66) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10449258-B2 | Antibody drug conjugate, intermediate, preparation method, pharmaceutical composition and uses thereof | XDCEXPLORER (SHANGHAI) CO., LTD. (CN) | 2019-10-22 | — | — | US | disclosed |
| US-20180161446-A1 | ANTIBODY DRUG CONJUGATE, INTERMEDIATE, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USES THEREOF | XDCEXPLORER (SHANGHAI) CO., LTD. (CN) | 2018-06-14 | — | — | US | disclosed |
| EP-3308801-A1 | ANTIBODY DRUG CONJUGATE, INTERMEDIATE, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USES THEREOF | XDCExplorer (Shanghai) Co., Ltd. (CN) | 2018-04-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10449258-B2 | Antibody drug conjugate, intermediate, preparation method, pharmaceutical composition and uses thereof | FCGR3B, SI, INCENP | TUBB4A 1299/4885TUBB 1041/4885TUBA3C 916/4885 |
| US-20180161446-A1 | ANTIBODY DRUG CONJUGATE, INTERMEDIATE, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USES THEREOF | FCGR3B, SI, INCENP | TUBB4A 1299/4885TUBB 1041/4885TUBA3C 916/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.